Case Report of acute myeloid leukemia with “WT1, ATRX, CEBPA, CSMD1, IKZF1, and LRP1B mutation and translocation between chromosome 1 and 19” developing from Philadelphia-negative chronic myeloid leukemia after TKI therapy

RATIONALE: The success of tyrosine kinase inhibitor (TKI) therapy has greatly prolonged the survival time of patients with chronic myeloid leukemia (CML), harboring the characteristic Philadelphia (Ph) chromosome. However, a fraction of patients, achieving complete cytogenetic response after TKI the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Huan, Yang, Bin, Liu, Jia, Wu, Wei, Ling, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220085/
https://www.ncbi.nlm.nih.gov/pubmed/32011516
http://dx.doi.org/10.1097/MD.0000000000018888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220085/
https://www.ncbi.nlm.nih.gov/pubmed/32011516
http://dx.doi.org/10.1097/MD.0000000000018888

Ejemplares similares